Loading...
Akerna Corp.
KERNW•NASDAQ
Healthcare
Medical - Healthcare Information Services
$0.001
$0.00(40.00%)

Financial performance has remained strong, with revenue growing from $2.85M in Q4 2022 to $2.08M in Q3 2023. Gross profit continued to perform well, with margins at 53% in the latest quarter. Operating income reached -$2.58M in Q3 2023, holding a steady -124% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$801373.00. Net income rose to -$2.59M, keeping EPS at -$0.32. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan